Meta-collaborations: A Call to Action

Tuesday, June 26
8:00-9:30AM ET

What are the barriers that are keeping ideas from turning into action? How can these barriers be broken to develop new models for innovation and collaboration? High-level thought leaders will address these questions and explore how industry, academia, government, and patients, through meta-collaborations, can take drug discovery to the next level.



Peter Adamson Peter C. Adamson, MD
Chief, Division of Clinical Pharmacology
and Therapeutics; Chair, Children’s Oncology Group
Children’s Hospital of Philadelphia

Margaret A. AndersonMargaret A. Anderson
Executive Director, FasterCures 
Kathy L. Hudson, PhDKathy L. Hudson, PhD
Deputy Director for Science, Outreach, and Policy
National Institutes of Health
Freda Lewis-Hall, MDFreda Lewis-Hall, MD
Chief Medical Officer and Senior Vice President, Pfizer Inc 
Stephen Spielberg, MD, PhDStephen Spielberg, MD, PhD
Deputy Commissioner, Medical Products and Tobacco, Office of the Commissioner
© 2018 DIA